Drug intelligence / Profile preview

shRNA-Notch3

Development stage
Preclinical
Lead developer
University of Arkansas for Medical Sciences
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

shRNA-Notch3 is a short hairpin RNA (shRNA) therapeutic candidate designed to knockdown the expression of the Notch3 receptor. In multiple myeloma (MM), Notch3 signaling between myeloma cells and osteocytes in the bone marrow niche promotes tumor proliferation and bone destruction. By reducing the protein levels of the active Notch3 intracellular domain (NICD3), this shRNA approach inhibits downstream Notch target genes and cyclinD1, leading to decreased MM cell proliferation and increased apoptosis. Preclinical studies in mouse models have demonstrated that Notch3 knockdown significantly reduces tumor burden and osteolytic lesions, suggesting that targeting Notch3 in the tumor microenvironment is a viable strategy for treating MM and its associated bone disease.

Other names
Notch3 shRNANotch-3 shRNANotch 3 shRNAshort hairpin RNA against Notch3
02

Targets

NOTCH (Neurogenic locus notch homolog protein 3)

Beyond the preview

Go deeper on shRNA-Notch3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shRNA-Notch3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call